CDCP1 and cancer: Fbxl4 induces the ubiquitination and degradation of CUB-domain-containing protein 1 (CDCP1), a transmembrane adaptor protein, identified as a malignant prognostic marker in several types of cancers, such as acute myeloid leukemia [145].